Burden of hereditary transthyretin amyloidosis on quality of life

INTRODUCTION: Hereditary transthyretin (hATTR) amyloidosis is a progressive, degenerative disease, with peripheral neuropathy, cardiomyopathy, and other clinical manifestations. In this study we examine the impact of hATTR amyloidosis on quality of life (QOL). METHODS: Neuropathy‐specific QOL, measu...

Descripción completa

Detalles Bibliográficos
Autores principales: Yarlas, Aaron, Gertz, Morie A., Dasgupta, Noel R., Obici, Laura, Pollock, Michael, Ackermann, Elizabeth J., Lovley, Andrew, Kessler, Asia Sikora, Patel, Pankaj A., White, Michelle K., Guthrie, Spencer D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Clinical Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771567/
https://www.ncbi.nlm.nih.gov/pubmed/31093980
http://dx.doi.org/10.1002/mus.26515

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771567/
https://www.ncbi.nlm.nih.gov/pubmed/31093980
http://dx.doi.org/10.1002/mus.26515

Ejemplares similares